1. Scrip

UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine

First Vaccinations To Begin Next Week

 
• By Andrew McConaghie

The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.  

BioNTech/Pfizer vaccine
The emergency authorization of Pfizer/BioNTech's BNT162b2 is the first anywhere in the world (ROCKSTEIN fotografie)

Pfizer Inc. and BioNTech have achieved an historic first "approval" for their COVID-19 vaccine, gaining emergency authorization in the UK.

The authorization for BNT162b2 is the first anywhere in the world, and is a breakthrough against the SARS-Cov-2 pandemic, with regulators in the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

‘Unprecedented’ Data Lift AstraZeneca’s Ambitions For Airsupra

 
• By Kevin Grogan

The company hopes the drug will become the standard of care rescue treatment in asthma.

Pipeline Watch: Eight Approvals And Nineteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: Trump’s executive order more rhetoric than action; industry grapples with Trump pricing plan; Hengrui set for this year’s biggest IPO; Sanofi’s exec’s advice to biotechs; and biotech deal return on investment falls.